MedPath

FUKUSHIMA MEDICAL UNIVERSITY HOSPITAL

🇯🇵Japan
Ownership
-
Established
1951-01-01
Employees
-
Market Cap
-
Website
https://www.fmu.ac.jp/byoin/

Clinical Trials

7

Active:0
Completed:3

Trial Phases

2 Phases

Phase 2:2
Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (66.7%)
Phase 2
2 (33.3%)

S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer

Phase 2
Conditions
Gastric Cancer
First Posted Date
2005-08-24
Last Posted Date
2013-09-17
Lead Sponsor
Fukushima Medical University Hospital
Target Recruit Count
70
Registration Number
NCT00134095
Locations
🇯🇵

Yamamoto Kumiai General Hospital, Noshiro, Akita, Japan

🇯🇵

Asahikawa Kosei General Hospital, Asahikawa, Hokkaido, Japan

🇯🇵

Kobe City General Hospital, Kobe, Hyogo, Japan

and more 4 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.